Abstract

Research Article

Detection of extended-spectrum betalactamase and carbapenemase-producing Enterobacteriaceae in Tunisia

Rahma Trabelsi*, Mariem Yengui, Amel Mhaya, Ahmed Rebai, Corinne Arpin and Radhouane Gdoura

Published: 15 March, 2023 | Volume 7 - Issue 1 | Pages: 001-011

The emergence of dramatic urinary tract infections (UTIs) caused by the members of the Enterobacteriales is an important public health problem in the community as well as in Tunisian hospitals. This study aims to investigate the prevalence of extended-spectrum β-lactamase (ESBL) and carbapenemase-producing uropathogenic isolates of Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae). 
Based on decreased susceptibility to β-lactams antibiotics and analyzed for the presence of ESBL and carbapenemase genes by Real Time- polymerase chain reaction (RT-PCR), 56 uropathogenic isolates of E. coli (n = 36) and K. pneumoniae (n = 20) were confirmed positive for ESBLs. The CTX-M-type β-lactamases were mostly detected in E. coli isolates (21 strains, 58.33% [95% CI 38.09% - 72.06%]) followed by blaSHV-like (18 strains, 50% [95% CI 32.92% - 67.07%]), blaTEM-like and blaCMY-2-like simultaneously (15 strains, 41.67% [95% CI 25.51% - 59.24%]). Furthermore, the RT-PCR system on the K. pneumoniae strains demonstrated that blaSHV-12-like was the most predominant (16 strains, 80% [95% CI 56.33% - 94.26%]) followed by blaTEM-like (14 strains, 70% [95% CI 45.72% - 88.10%]), blaCTX-M belonging to groups 9 and 1 (11 strains, 55% [95% CI 31.52% - 76.94%]) and finally blaCMY-2-like (10 strains, 50% [95% CI 27.19% - 72.80%]). In addition, E. coli and K. pneumoniae strains harbored a carbapenemase gene blaOXA-48-like with 22.2% [95% CI 10.11% - 39.15%]; 20% [95% CI 12.83% - 43.66%], respectively.
Our results confirm the need to monitor the resistance to extended-spectrum β-lactams and to carbapenems among enterobacteria in Tunisia.

Read Full Article HTML DOI: 10.29328/journal.abb.1001034 Cite this Article Read Full Article PDF

Keywords:

UTIs; ESBL-producing; E. coli; K. pneumonia; CTX-M-type; Beta-lactamase and carbapenemase genes

References

  1. Lee DS, Lee SJ, Choe HS. Community-Acquired Urinary Tract Infection by Escherichia coliin the Era of Antibiotic Resistance. Biomed Res Int. 2018 Sep 26;2018:7656752. doi: 10.1155/2018/7656752. PMID: 30356438; PMCID: PMC6178185.
  2. Nordmann P, Poirel L. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect. 2014 Sep;20(9):821-30. doi: 10.1111/1469-0691.12719. PMID: 24930781.
  3. Shakya P, Shrestha D, Maharjan E, Sharma VK, Paudyal R. ESBL Production Among  coliand Klebsiella spp. Causing Urinary Tract Infection: A Hospital Based Study. Open Microbiol J. 2017 Apr 28;11:23-30. doi: 10.2174/1874285801711010023. PMID: 28553414; PMCID: PMC5427687.
  4. Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010 Sep;74(3):417-33. doi: 10.1128/MMBR.00016-10. PMID: 20805405; PMCID: PMC2937522.
  5. Poirel L, Pitout JD, Nordmann P. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol. 2007 Oct;2(5):501-12. doi: 10.2217/17460913.2.5.501. PMID: 17927473.
  6. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev. 2014; 18:1–36.
  7. Jena J, Sahoo RK, Debata NK, Subudhi E. Prevalence of TEM, SHV, and CTX-M genes of extended-spectrum β-lactamase-producing Escherichia coli strains isolated from urinary tract infections in adults. 3 Biotech. 2017 Aug;7(4):244. doi: 10.1007/s13205-017-0879-2. Epub 2017 Jul 14. PMID: 28710743; PMCID: PMC5511117.
  8. Cantón R, González-Alba JM, Galán JC. CTX-M Enzymes: Origin and Diffusion. Front Microbiol. 2012 Apr 2;3:110. doi: 10.3389/fmicb.2012.00110. PMID: 22485109; PMCID: PMC3316993.
  9. Poirel L, Héritier C, Tolün V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2004 Jan;48(1):15-22. doi: 10.1128/AAC.48.1.15-22.2004. PMID: 14693513; PMCID: PMC310167.
  10. Carrër A, Poirel L, Yilmaz M, Akan OA, Feriha C, Cuzon G, Matar G, Honderlick P, Nordmann P. Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob Agents Chemother. 2010 Mar;54(3):1369-73. doi: 10.1128/AAC.01312-09. Epub 2010 Jan 19. PMID: 20086157; PMCID: PMC2825965.
  11. Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011 Oct;17(10):1791-8. doi: 10.3201/eid1710.110655. PMID: 22000347; PMCID: PMC3310682.
  12. N G M, C Math G, Nagshetty K, Patil SA, Gaddad SM, Shivannavar CT. Antibiotic Susceptibility Pattern of ESβL Producing Klebsiella pneumoniae Isolated from Urine Samples of Pregnant Women in Karnataka. J Clin Diagn Res. 2014 Oct;8(10):DC08-11. doi: 10.7860/JCDR/2014/9594.5048. Epub 2014 Oct 20. PMID: 25478341; PMCID: PMC4253159.
  13. Kiratisin P, Apisarnthanarak A, Laesripa C, Saifon P. Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother. 2008 Aug;52(8):2818-24. doi: 10.1128/AAC.00171-08. Epub 2008 May 27. PMID: 18505851; PMCID: PMC2493136.
  14. Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med. 2012 May;18(5):263-72. doi: 10.1016/j.molmed.2012.03.003. Epub 2012 Apr 3. PMID: 22480775.
  15. Carattoli A. Animal reservoirs for extended spectrum beta-lactamase producers. Clin Microbiol Infect. 2008 Jan;14 Suppl 1:117-23. doi: 10.1111/j.1469-0691.2007.01851.x. Erratum in: Clin Microbiol Infect. 2008 May;14 Suppl 5:21-4. PMID: 18154535.
  16. Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J, Voets GM, van den Munckhof MP, van Essen-Zandbergen A, Platteel T, Fluit AC, van de Sande-Bruinsma N, Scharinga J, Bonten MJ, Mevius DJ; National ESBL surveillance group. Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect. 2011 Jun;17(6):873-80. doi: 10.1111/j.1469-0691.2011.03497.x. Epub 2011 Apr 4. PMID: 21463397.
  17. Saïdani M, Hammami S, Kammoun A, Slim A, Boutiba-Ben Boubaker I. Emergence of carbapenem-resistant OXA-48 carbapenemase-producing Enterobacteriaceae in Tunisia. J Med Microbiol. 2012 Dec;61(Pt 12):1746-1749. doi: 10.1099/jmm.0.045229-0. Epub 2012 Aug 23. PMID: 22918869.
  18. Chin TL, McNulty C, Beck C, MacGowan A. Antimicrobial resistance surveillance in urinary tract infections in primary care. J Antimicrob Chemother. 2016 Oct;71(10):2723-8. doi: 10.1093/jac/dkw223. Epub 2016 Jun 26. PMID: 27353470.
  19. O'Hara CM, Rhoden DL, Miller JM. Reevaluation of the API 20E identification system versus conventional biochemicals for identification of members of the family Enterobacteriaceae: a new look at an old product. J Clin Microbiol. 1992 Jan;30(1):123-5. doi: 10.1128/jcm.30.1.123-125.1992. PMID: 1734043; PMCID: PMC265006.
  20. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 26 th informational supplement. Wayne: CLSI 2016.
  21. Kumar D, Singh AK, Ali MR, Chander Y. Antimicrobial Susceptibility Profile of Extended Spectrum β-Lactamase (ESBL) Producing Escherichia coli from Various Clinical Samples. Infect Dis (Auckl). 2014 Mar 25;7:1-8. doi: 10.4137/IDRT.S13820. PMID: 24847178; PMCID: PMC4024053.
  22. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988 Jul-Aug;10(4):867-78. doi: 10.1093/clinids/10.4.867. PMID: 3263690.
  23. Stapleton PD, Shannon KP, French GL. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein. Antimicrob Agents Chemother. 1999 May;43(5):1206-10. doi: 10.1128/AAC.43.5.1206. PMID: 10223937; PMCID: PMC89134.
  24. Quiles MG, Menezes LC, Bauab KC, Gumpl EK, Rocchetti TT, Palomo FS, Carlesse F.(2015).Diagnosis of bacteremia in pediatric oncologic patients by in-house real-time PCR. BMC Infect Dis. :15:283.
  25. Kubista M, Andrade JM, Bengtsson M, Forootan A, Jonák J, Lind K, Sindelka R, Sjöback R, Sjögreen B, Strömbom L, Ståhlberg A, Zoric N. The real-time polymerase chain reaction. Mol Aspects Med. 2006 Apr-Jun;27(2-3):95-125. doi: 10.1016/j.mam.2005.12.007. Epub 2006 Feb 3. PMID: 16460794.
  26. Mumbula E, Kwenda G, Samutela M, Kalonda A, Mwansa J, Mwenya D, Koryolova L, Kaile T, Marimo C, Lukwesa –Musyani C. Extended spectrum b-lactamases producing Klebsiella pneumoniae from the neonatal intensive care unit at the university teaching hospital in Lusaka, Zambia. J Med Sci Technol. 2015;4:85–91.
  27. Caroff N, Espaze E, Bérard I, Richet H, Reynaud A. Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum beta-lactamase production. FEMS Microbiol Lett. 1999 Apr 15;173(2):459-65. doi: 10.1111/j.1574-6968.1999.tb13539.x. PMID: 10227175.
  28. Cantón R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, Coque TM. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect. 2008 Jan;14 Suppl 1:144-53. doi: 10.1111/j.1469-0691.2007.01850.x. Erratum in: Clin Microbiol Infect. 2008 May;14 Suppl 5:21-4. PMID: 18154538.
  29. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother. 2011 Jan;66(1):1-14. doi: 10.1093/jac/dkq415. Epub 2010 Nov 16. PMID: 21081548.
  30. Al-Agamy MH, Shibl AM, Hafez MM, Al-Ahdal MN, Memish ZA, Khubnani H. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Riyadh: emergence of CTX-M-15-producing E. coli ST131. Ann Clin Microbiol Antimicrob. 2014 Jan 7;13:4. doi: 10.1186/1476-0711-13-4. PMID: 24397567; PMCID: PMC3898780.
  31. Rezai MS, Salehifar E, Rafiei A, Langaee T, Rafati M, Shafahi K, Eslami G. Characterization of Multidrug Resistant Extended-Spectrum Beta-Lactamase-Producing Escherichia coli among Uropathogens of Pediatrics in North of Iran. Biomed Res Int. 2015;2015:309478. doi: 10.1155/2015/309478. Epub 2015 May 3. PMID: 26064896; PMCID: PMC4433631.
  32. ElBouamri MC, Arsalane L, El Kamouni Y, Zouhair S. Antimicrobial susceptibility of urinary Klebsiella pneumoniae and the emergence of carbapenem-resistant strains: A retrospective study from a university hospital in Morocco, North Africa. African Journal of Urology. 2015; 1110-5704.
  33. Bazzaz BS, Naderinasab M, Mohamadpoor AH, Farshadzadeh Z, Ahmadi S, Yousefi F. The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates from a general hospital in Iran. Acta Microbiol Immunol Hung. 2009 Mar;56(1):89-99. doi: 10.1556/AMicr.56.2009.1.7. PMID: 19388560.
  34. Elhani D, Bakir L, Aouni M, Passet V, Arlet G, Brisse S, Weill FX. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains in a university hospital in Tunis, Tunisia, 1999-2005. Clin Microbiol Infect. 2010 Feb;16(2):157-64. doi: 10.1111/j.1469-0691.2009.03057.x. Epub 2009 Sep 21. PMID: 19769601.
  35. Mamlouk K, Boutiba-Ben Boubaker I, Gautier V, Vimont S, Picard B, Ben Redjeb S, Arlet G. Emergence and outbreaks of CTX-M beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains in a Tunisian hospital. J Clin Microbiol. 2006 Nov;44(11):4049-56. doi: 10.1128/JCM.01076-06. Epub 2006 Sep 6. PMID: 16957046; PMCID: PMC1698301.
  36. Ferjani S, Saidani M, Ennigrou S, Hsairi M, Slim AF, Ben Boubaker IB. Multidrug resistance and high virulence genotype in uropathogenic Escherichia coli due to diffusion of ST131 clonal group producing CTX-M-15: an emerging problem in a Tunisian hospital. Folia Microbiol (Praha). 2014 May;59(3):257-62. doi: 10.1007/s12223-013-0292-0. Epub 2013 Nov 21. PMID: 24258848.
  37. Lahlaoui H, Anis BH, Mohamed K, Mohamed BM. Emergence of SHV-12 extended spectrum beta-lactamase among clinical isolates of Enterobacter cloacae in Tunisia. Microb Pathog. 2012 Aug;53(2):64-5. doi: 10.1016/j.micpath.2012.04.003. Epub 2012 Apr 21. PMID: 22543154.
  38. Agabou A, Pantel A, Ouchenane Z, Lezzar N, Khemissi S, Satta D, Sotto A, Lavigne JP. First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria. Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1641-6. doi: 10.1007/s10096-014-2122-y. Epub 2014 May 5. PMID: 24792128.
  39. Ben Slama K, Ben Sallem R, Jouini A, Rachid S, Moussa L, Sáenz Y, Estepa V, Somalo S, Boudabous A, Torres C. Diversity of genetic lineages among CTX-M-15 and CTX-M-14 producing Escherichia coli strains in a Tunisian hospital. Curr Microbiol. 2011 Jun;62(6):1794-801. doi: 10.1007/s00284-011-9930-4. Epub 2011 Apr 10. PMID: 21479796.
  40. Gomi R, Matsuda T, Matsumura Y, Yamamoto M, Tanaka M, Ichiyama S, Yoneda M. Occurrence of Clinically Important Lineages, Including the Sequence Type 131 C1-M27 Subclone, among Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Wastewater. Antimicrob Agents Chemother. 2017 Aug 24;61(9):e00564-17. doi: 10.1128/AAC.00564-17. PMID: 28630184; PMCID: PMC5571296.
  41. Girlich D, Bouihat N, Poirel L, Benouda A, Nordmann P. High rate of faecal carriage of extended-spectrum β-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a university hospital in Morocco. Clin Microbiol Infect. 2014 Apr;20(4):350-4. doi: 10.1111/1469-0691.12325. Epub 2013 Aug 9. PMID: 23927757.
  42. Khalaf NG, Eletreby MM, Hanson ND. Characterization of CTX-M ESBLs in Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae clinical isolates from Cairo, Egypt. BMC Infect Dis. 2009 Jun 4;9:84. doi: 10.1186/1471-2334-9-84. PMID: 19497111; PMCID: PMC2701952.
  43. Dortet L, Poirel L, Nordmann P. Rapid identification of carbapenemase types in Enterobacteriaceae and Pseudomonas spp. by using a biochemical test. Antimicrob Agents Chemother. 2012 Dec;56(12):6437-40. doi: 10.1128/AAC.01395-12. Epub 2012 Oct 15. PMID: 23070158; PMCID: PMC3497194.
  44. Ktari S, Mnif B, Louati F, Rekik S, Mezghani S, Mahjoubi F, Hammami A. Spread of Klebsiella pneumoniae isolates producing OXA-48 β-lactamase in a Tunisian university hospital. J Antimicrob Chemother. 2011 Jul;66(7):1644-6. doi: 10.1093/jac/dkr181. Epub 2011 May 11. PMID: 21565807.
  45. Mhaya A, Trabelsi R, M'Zali F, Bégu D, Tounsi S, Gdoura R, Arpin C. First description of NDM-1-positive Klebsiella pneumoniae in the Tunisian community. J Glob Antimicrob Resist. 2020 Jun;21:49-50. doi: 10.1016/j.jgar.2020.02.023. Epub 2020 Mar 10. PMID: 32169682.
  46. Charfi K, Mansour W, Khalifa AB, Mastouri M, Aouni M, Mammeri H. Emergence of OXA-204 β-lactamase in Tunisia. Diagn Microbiol Infect Dis. 2015 Aug;82(4):314-7. doi: 10.1016/j.diagmicrobio.2015.04.003. Epub 2015 Apr 24. PMID: 26001616.

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?